The head of troubled Canadian pharmaceutical company Valeant Pharmaceuticals Inc. has been hospitalized.
Valeant spokeswoman Laurie Little said in an emailed statement that Chief Executive Michael Pearson has been admitted for “severe” pneumonia. No other details were given.
Last week, the company, based in suburban Montreal, slashed its fourth-quarter financial predictions and issued a profit outlook for 2016 that was short of Wall Street's estimate.
The company had grown rapidly since...